Tetraphase Pharmaceuticals Inc. (TTPH)

0.40
NASDAQ : Health Technology
Prev Close 0.41
Day Low/High 0.40 / 0.43
52 Wk Low/High 0.40 / 3.66
Avg Volume 589.80K
Exchange NASDAQ
Shares Outstanding 54.26M
Market Cap 22.38M
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
IMPORTANT DEADLINE REMINDER: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

IMPORTANT DEADLINE REMINDER: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

EQUITY ALERT UPDATE: Rosen Law Firm Expands Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. On Behalf Of Options Purchasers And Sellers

EQUITY ALERT UPDATE: Rosen Law Firm Expands Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. On Behalf Of Options Purchasers And Sellers

Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of all purchasers of the common stock and call options and sellers of put options of Tetraphase Pharmaceuticals, Inc.

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Tetraphase Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Tetraphase Pharmaceuticals, Inc. And Urges Investors To Contact The Firm

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation Of Tetraphase Pharmaceuticals, Inc. And Urges Investors To Contact The Firm

Lundin Law PC announces it is investigating claims against Tetraphase Pharmaceuticals, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tetraphase Pharmaceuticals Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Tetraphase Pharmaceuticals Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Tetraphase Pharmaceuticals Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of March 28, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2015 Financial Results And Provides Corporate Update

Tetraphase Pharmaceuticals Reports Fourth-Quarter And Full-Year 2015 Financial Results And Provides Corporate Update

- Company to Host Conference Call at 4:30 p.m. ET Today -

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016 - TTPH

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving Tetraphase Pharmaceuticals Inc. And A Lead Plaintiff Deadline Of March 28, 2016 - TTPH

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Tetraphase Pharmaceuticals Inc.

What Carl Icahn Is Doing; Biotech Breakout: Best of Kass

What Carl Icahn Is Doing; Biotech Breakout: Best of Kass

Doug Kass looks at Carl Icahn's actions on Apple and the breakout in biotech stocks.

STOCK NOTICE: Rosen Law Firm Reminds Tetraphase Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action- TTPH

STOCK NOTICE: Rosen Law Firm Reminds Tetraphase Pharmaceuticals, Inc. Investors Of Important Deadline In Class Action- TTPH

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tetraphase Pharmaceuticals, Inc.

JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views

JPMorgan, Deutsche Bank and Gilead Sciences: Doug Kass' Views

Doug Kass shares his views on the health of the banking sector and why he's buying biotech.

Tetraphase Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Tetraphase Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit...

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Tetraphase Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Tetraphase Pharmaceuticals, Inc.

SHAREHOLDER ALERT: Scott + Scott, LLP Reminds Shareholders Of Important Deadline In Securities Lawsuit Against Tetraphase Pharmaceuticals Inc. -- TTPH

SHAREHOLDER ALERT: Scott + Scott, LLP Reminds Shareholders Of Important Deadline In Securities Lawsuit Against Tetraphase Pharmaceuticals Inc. -- TTPH

Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, hereby notifies investors that a class action lawsuit has been filed on behalf of all investors who purchased shares of Tetraphase Pharmaceuticals Inc.

Tetraphase Pharmaceuticals Enters Oversold Territory (TTPH)

Tetraphase Pharmaceuticals Enters Oversold Territory (TTPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Tetraphase Pharmaceuticals (TTPH): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial For TP-271

Tetraphase Pharmaceuticals Initiates Phase 1 Clinical Trial For TP-271

First Human Patient Dosed in Trial Evaluating Novel Antibiotic Candidate Being Developed for Bacterial Respiratory Infections With Support From National Institute of Allergy and Infectious Diseases

Short Interest In Tetraphase Pharmaceuticals Decreases By 10.6%

Short Interest In Tetraphase Pharmaceuticals Decreases By 10.6%

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 636,108 share decrease in total short interest for Tetraphase Pharmaceuticals, Inc , to 5,379,230, a decrease of 10.57% since 12/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Tetraphase Pharmaceuticals (TTPH) Is Weak On High Volume Today

Trade-Ideas LLC identified Tetraphase Pharmaceuticals (TTPH) as a weak on high relative volume candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Tetraphase Pharmaceuticals, Inc. And Certain Officers And Directors

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud By Tetraphase Pharmaceuticals, Inc. And Certain Officers And Directors

Levi & Korsinsky, LLP announces that it has commenced an investigation of Tetraphase Pharmaceuticals, Inc.

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look poised to break out and trade higher from current levels.

TheStreet Quant Rating: D (Sell)